Biotech_Inventory [9]
All categoriesUAE-flagship for precision medicine and advanced engineering.
Drug discovery, synthetic biology, longevity, computational biology — names with clinical-grade weight.
Biotech is the most capital-intensive category in deep tech, and the brands that win operate at clinical-credibility standards from day one. A premium .com is not vanity here — it's the first signal to physicians, regulators, pharma partners, and institutional investors that a serious team is behind the science. Descriptive naming (Bio-, Gene-, Cell-, Therapeutics-) is saturated; distinctive brandable domain names travel better through the FDA, NEJM, and Series B pitch decks.
These biotech domains for sale fit platform biotech, therapeutics, diagnostics, longevity, synthetic biology, and the computational layer increasingly central to modern drug discovery. Every name is short, phonetic, and .com — designed to hold up on a Nature paper byline, a clinical-trial registration, and a public-market ticker debut with equal weight.
Pricing reality for 2026: brandable biotech .coms trade at $15K–$60K depending on category fit, with the computational-bio and AI-drug-discovery segments repricing fastest as Xaira, Isomorphic, and Recursion set naming comparables. Every domain below transfers via Afternic escrow with lease-to-own available.
UAE-flagship for precision medicine and advanced engineering.